2020 CPDD Reviewer Thank You List.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 326, doi. 10.1002/cpdd.932
- Publication type:
- Article
Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 3
Results: 13
1
2
Model‐Informed Drug Development for Long‐Acting Injectable Products: Summary of American College of Clinical Pharmacology Symposium.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 220, doi. 10.1002/cpdd.928
- By:
- Publication type:
- Article
3
Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 241, doi. 10.1002/cpdd.909
- By:
- Publication type:
- Article
4
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 229, doi. 10.1002/cpdd.899
- By:
- Publication type:
- Article
5
Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 307, doi. 10.1002/cpdd.887
- By:
- Publication type:
- Article
6
Clinical and Model‐Based Evaluation of the Effect of Glasdegib on Cardiac Repolarization From a Randomized Thorough QT Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 272, doi. 10.1002/cpdd.862
- By:
- Publication type:
- Article
7
Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 260, doi. 10.1002/cpdd.846
- By:
- Publication type:
- Article
8
Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony‐Stimulating Factor in Healthy Chinese Subjects: An Open‐Label, Randomized, Parallel‐Design Bioavailability Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 291, doi. 10.1002/cpdd.819
- By:
- Publication type:
- Article
9
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 299, doi. 10.1002/cpdd.844
- By:
- Publication type:
- Article
10
Effects of Oxycodone Combined With Flurbiprofen Axetil on Postoperative Analgesia and Immune Function in Patients Undergoing Radical Resection of Colorectal Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 251, doi. 10.1002/cpdd.818
- By:
- Publication type:
- Article
11
The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two‐Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 283, doi. 10.1002/cpdd.843
- By:
- Publication type:
- Article
12
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 215, doi. 10.1002/cpdd.710
- Publication type:
- Article
13
A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 317, doi. 10.1002/cpdd.816
- By:
- Publication type:
- Article